Rajeev Saggar - Jul 18, 2022 Form 4 Insider Report for Liquidia Corp (LQDA)

Role: Chief Medical Officer
Signature: /s/ Dr. Rajeev Saggar
Stock symbol: LQDA
Transactions as of: Jul 18, 2022
Transactions value $: $0
Form type: 4
Date filed: 7/20/2022, 04:31 PM
Next filing: Jan 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LQDA	Common Stock	Award	$0	+93.8K		$0.00	93.8K	Jul 18, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LQDA	Non-Qualified Stock Option (Right to Buy)	Award	$0	+200K		$0.00	200K	Jul 18, 2022	Common Stock	200K	$3.73	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2	50% of the RSUs shall vest on July 18, 2023 and the remaining RSUs shall vest ratably on a quarterly basis over two years thereafter, subject to the Reporting Person's employment with the Issuer on each such vesting date; provided, however, that the RSUs shall become fully vested in the event that the Reporting Person's employment is terminated due to his death or Disability or is terminated by the Company without Cause (as such terms are defined in the Reporting Person's Employment Agreement).
F3	The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, subject to the Reporting Person's employment with the Issuer on each such vesting date.